(Q46698218)

24 December 2017

title

Intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion (English)

1 reference

24 December 2017

1 reference

K Gündüz

1

1 reference

24 December 2017

S J Bakri

series ordinal

2

1 reference

24 December 2017

publication date

14 March 2008

1 reference

24 December 2017

published in

Eye

1 reference

24 December 2017

volume

22

1 reference

24 December 2017

issue

9

1 reference

24 December 2017

page(s)

1168-1171

1 reference

24 December 2017

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703040

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703040

Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703040

Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703040

Pharmacokinetics of intravitreal ranibizumab (Lucentis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703040

Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703040

Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703040

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703040

Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703040

7 January 2021

Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703040

7 January 2021

Pharmacokinetics of intravitreal bevacizumab (Avastin)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703040

7 January 2021

Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6703040

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6703040

1 reference

24 December 2017

Dimensions Publication ID

1017065751

0 references

1 reference

24 December 2017